Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HUMANITY: Human Acellular Vessel vs ePTFE Grafts for Hemodialysis
NCT02644941Phase 3Completed
- Sponsor
- Humacyte
- Start
- May 2016
- Primary completion
- May 2019
- Countries
- 6
01
Overview
A Phase 3 trial of acellular tissue engineered vessel in end stage renal disease (ESRD), sponsored by Humacyte. Started May 2016; status: completed.
02
Drugs
acellular tissue engineered vessel
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT02644941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644941.